References
- Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviotto C, Basso M, et al. Nailfold videocapillaroscopic patterns and serum antibodies in systemic sclerosis. Rheumathology. 2004;43(6):719-26.
- Almeida C, Almeida I, Vasconcelos C. Quality of life in systemic sclerosis. Autoimmun Rev. 2015;14(12):1087-96.
- Plazak W, Zabinska-Plazak E, Wojas Pelc A, Podolec P, Olszowka M, Tracz W, et al. Heart structure and function in systemic sclerosis. Eur J Dermatol. 2002;12(3):257-62.
- D’Andrea A, D’Alto M, Di Maio M, Vettori S, Benjamin N, Cocchia R, et al. Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study. Clin Rheumatol. 2016;35(7):1733-42.
- Karna SK, Rohit MK, Wanchu A. Right ventricular thickness as predictor of global myocardial performance in systemic sclerosis: a doppler tissue imaging study. Indian Heart J. 2015;67(6):521-8.
- Hassoun PM. The right ventricle in scleroderma (2013 Grover Conference Series). Pulm Circ. 2015;5(1):3-14.
- D’Andrea A, D’Alto M, Di Maio M, Vettori S, Benjamin N, Cocchia R, et al. Right atrial morphology and function in patients with systemic sclerosis compared to healthy controls: a two-dimensional strain study. Clin Rheumatol. 2016;35(7):1733-42.
- Karna SK, Rohit MK, Wanchu A. Right ventricular thickness as predictor of global myocardial performance in systemic sclerosis: a doppler tissue imaging study. Indian Heart J. 2015;67(6):521-8.
- Champion HC. The Heart in Scleroderma. Rheum Dis Clin North Am. 2008;34(1):181–90.
- Lambova S. Cardiac manifestations in systemic sclerosis. World J Cardiol; 2014;6(9): 993-1005.
- Varga J, Denton CP, Wigley FM. Scleroderma. New York: Springer. 2012;361-371;373-395.
- Dinser R, Frerix M, Meier FM, Klingel K, Rolf A. Endocardial and myocardial involvement in systemic sclerosis-is there a relevant inflammatory component? Jt Bone Spine. 2013;80(3):320-3.
- Vacca A, Meune C, Gordon J, Chung L, Proudman S, Assassi S, et al. Cardiac arrhythmias and conduction defects in systemic sclerosis. Rheumatology. 2014;53(7):1172-7.
- Lubitz SA, Goldbarg SH, Mehta D. Sudden cardiac death in infiltrative cardiomyopathies: sarcoidosis, scleroderma, amyloidosis, hemachromatosis. Prog Cardiovasc Dis. 2008;51(1): 58-73.
- Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809-15.
- Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, et al. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheumatol. 2008;58(6): 1803-9.
- Meune C, Vignaux O, Kahan A, Allanore Y. Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis. 2010;103(1):46-52.
- Kružliak P, Kováčová G, Balogh S. Pericardial effusion as a first sign of systemic scleroderma. Cor et Vasa. 2012;54(4):e258-e260.
- Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26(10):2159–67.
- Draeger HT, Assassi S, Sharif R, Gonzalez EB, Harper BE, Arnett FC, et al. Right bundle branch block: a predictor of mortality in early systemic sclerosis. PLoS One. 2013;8(10):e78808.
- Amjadi S, Maranian P, Furst DE, Clements PJ, Wong WK, Postlethwaite AE, et al. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double‐ blind, randomized controlled trials. Arthritis Rheumatol. 2009 60(8):2490–8.
- Gigante A, Rosato E, Liberatori M, Sardo L, Di Paolo M, Marinelli P, et al. In systemic sclerosis prolonged QTc interval is associated with reduced exercise tolerance. Int J Cardiol. 2016;203:570-2.
- Munday FA, Asuri S, McIntosh S, Jackson H, Tang A, Arbour L. 2016. Increased Corrected QT Interval (QTc) in First Nations Women of Northern British Columbia with Systemic Lupus Erythematosus (SLE). Int J Clin Cardiol. 2016;3(072):10-23937.
- Biełous-Wilk A, Poreba M, Staniszewska-Marszałek E, Poreba R, Podgórski M, Kałka D, et al. Electrocardiographic evaluation in patients with systemic scleroderma and without clinically evident heart disease. Ann Noninvasive Electrocardiol. 2009;14(3):251-7.
- Bovenzi M, Barbone F, Pisa FE, Della Vedova A, Betta A, Romeo L, et al. Scleroderma and occupational risk factors: a case-control study. G Ital Med Lav Ergon. 2003;25(3):46-7.
- Mukherjee M, Chung SE, Ton VK, Tedford RJ, Hummers LK, Wigley FM, et al. 2016. Right Ventricular Strain in Systemic Sclerosis. Circ Cardiovasc Imaging. 2016;9(6):e003792.
- Jaeger VK, Distler O, Maurer B, Czirják L, Lóránd V, Valentini G, et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology. 2018;57(3):441-50.
- Van Den Hoogen F, Khanna D, Fransen J, Johnson SR., Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2013;65(11):2737-47.